Skip to main content
Clinical Trials/CTRI/2021/06/034001
CTRI/2021/06/034001
Active, not recruiting
Phase 2

Efficacy of low dose lung radiotherapy in the management of Covid-19 patients

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Sri Venkateswara Institute of Medical Sciences
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 40 years or more and 2\. Patients confirmed to have COVID\-19 based on a positive RT\_PCR for SARS CoV\-2 and have been admitted to the hospital and 3\. patients with any of a. PaO2/FiO2 between 100mmHg and 300mmHg or b. Respiratory rate \>24per min or more, breathlessness or c. SpO2 \<94% on room air and 4\. Lung parenchymal involvement at baseline CT scan

Exclusion Criteria

  • 1\.Pregnancy and lactating mother
  • 2\.Prior thoracic radiation or chemotherapy with potential for pulmonary toxicity
  • 3\.Prior or planned treatment with interleukin inhibitors or TNF\-α inhibitors
  • 4\.History of collagen vascular disease
  • 5\.Chronic lung diseases (Chronic obstructive lung disease, bronchial asthma), history of pulmonary tuberculosis
  • 6\.Inability to lie in supine on a flat couch with oxygen supplementation for radiation planning and delivery
  • 7\.Patients with PaO2/FiO2 \<100 (severe ARDS) and/or on mechanical ventilation
  • 8\.Patients who are not willing to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials